Tag: #M&A

Eli Lilly has agreed to acquire Ajax Therapeutics in a deal valued at up to $2.3 billion, featuring an upfront... Read more

Servier, a global independent pharmaceutical group, has concluded its tender offer for Day One Biopharmaceuticals, acquiring all outstanding common stock... Read more

On April 22, 2026, Amneal Pharmaceuticals announced its strategic acquisition of Kashiv BioSciences for $1.1 billion. This move positions Amneal... Read more

Eli Lilly has entered into a definitive agreement to acquire Kelonia Therapeutics for potential consideration of up to $7 billion.... Read more

Belgian pharmaceutical giant UCB announced on Friday its acquisition of Neurona Therapeutics for up to $1.2 billion. The move highlights... Read more

Vir Biotechnology has officially entered into a global strategic collaboration with Astellas Pharma. The agreement focuses on the co-development and... Read more

Eli Lilly has finalized a deal to acquire Houston-based startup CrossBridge Bio, marking its latest investment in the rapidly evolving... Read more

Indian pharmaceutical giant Sun Pharmaceutical is reportedly finalizing a binding offer to acquire Organon, a women's health-focused Merck & Co.... Read more